Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 17 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-1.64 Insider Own70.06% Shs Outstand43.59M Perf Week29.27%
Market Cap385.26M Forward P/E- EPS next Y-0.77 Insider Trans-1.42% Shs Float19.07M Perf Month63.96%
Income-60.18M PEG- EPS next Q-0.14 Inst Own37.36% Short Float2.10% Perf Quarter55.13%
Sales0.00M P/S- EPS this Y76.15% Inst Trans2.60% Short Ratio1.28 Perf Half Y38.44%
Book/sh1.40 P/B4.32 EPS next Y-53.98% ROA-76.37% Short Interest0.40M Perf Year13.94%
Cash/sh1.41 P/C4.29 EPS next 5Y- ROE-115.90% 52W Range2.00 - 13.00 Perf YTD29.55%
Dividend Est.- P/FCF- EPS past 5Y- ROI-98.64% 52W High-53.46% Beta0.34
Dividend TTM- Quick Ratio6.17 Sales past 5Y0.00% Gross Margin- 52W Low202.50% ATR (14)0.47
Dividend Ex-Date- Current Ratio6.17 EPS Y/Y TTM-867.93% Oper. Margin0.00% RSI (14)79.65 Volatility11.72% 11.78%
Employees15 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price17.80
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q99.43% Payout- Rel Volume1.41 Prev Close6.00
Sales Surprise- EPS Surprise91.40% Sales Q/Q- EarningsMay 09 BMO Avg Volume311.95K Price6.05
SMA2037.59% SMA5071.65% SMA20028.75% Trades Volume439,332 Change0.83%
Date Action Analyst Rating Change Price Target Change
May-03-24Initiated Piper Sandler Overweight $26
Oct-10-23Initiated Ladenburg Thalmann Buy $10
Aug-25-23Initiated Oppenheimer Outperform $17
Jun-22-23Initiated Guggenheim Buy $20
Jun-14-23Initiated Chardan Capital Markets Buy $14
May-24-23Initiated Raymond James Strong Buy $20
May-15-24 09:55AM
May-14-24 12:00PM
May-12-24 03:26PM
May-10-24 03:14PM
May-09-24 01:56PM
06:00AM Loading…
Apr-25-24 02:18AM
Apr-18-24 09:22AM
Apr-08-24 06:00AM
Mar-28-24 11:54AM
Mar-04-24 06:00AM
Feb-02-24 06:00AM
Jan-08-24 06:00AM
Jan-03-24 06:00AM
06:00AM Loading…
Dec-04-23 06:00AM
Nov-14-23 06:00AM
Nov-13-23 06:30AM
Sep-12-23 05:00AM
Sep-05-23 08:55PM
Aug-25-23 09:42AM
Aug-14-23 07:00AM
Jun-23-23 06:30AM
Jun-06-23 06:34AM
Jun-01-23 10:20AM
Apr-27-23 07:39AM
Apr-14-23 05:00AM
Mar-27-23 09:35AM
Mar-21-23 06:13AM
Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sidhu SomeitDirectorApr 22 '24Buy3.131,186,9013,715,0001,186,901Apr 24 06:51 PM
Munshi AmitDirectorApr 22 '24Buy3.13159,744499,999777,384Apr 24 06:52 PM
Howell MichaelSee RemarksApr 22 '24Buy3.137,98724,9997,987Apr 24 06:54 PM
Nistala KiranExecutive Vice PresidentApr 22 '24Buy3.133,19510,0003,195Apr 24 06:53 PM
Thiara ParvinderDirectorDec 12 '23Sale4.002,000,0008,000,0004,801,633Dec 14 03:35 PM
Munshi AmitDirectorJun 05 '23Buy4.25117,647500,000617,640Jun 05 07:15 PM